Get the SPI Wire

Grace Therapeutics, Inc.

NASDAQ:GRCE
Annual Meeting

of Shareholders

MEETING DATE

09/17/2026
DEF 14A FILED
07/28/2026
PUBLISHED
07/28/2026 8:29 pm
TIME TO PUBLISH
07/30/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:GRCE · CUSIP 00439U104 · CLASS common stock · CIK 0001444192

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

4
FOR
0
AGAINST
0
WITHHOLD
4
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect the five nominees for director named in this Proxy Statement for a one-year term expiring at the 2027 Annual Meeting of Stockholders
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the board nominated five directors for election to one-year terms.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve, on an advisory basis, the compensation of our named executive officers
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the Compensation Committee will consider the vote outcome in future compensation decisions.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2027
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states all billed services were pre-approved by the Audit Committee.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers.
compensation
Elevated
For
Board none · Duopoly unknown — ⚠ Divergence flagged

Filing states annual votes provide more direct and immediate feedback on annual compensation disclosures.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

21f57f619d1b27116cd381c70b7c1aa9379cbc289f653328133b2e74a2e60513

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates